Lee A K, Mackay I R, Rowley M J, Yap C Y
Clin Exp Immunol. 1971 Oct;9(4):507-18.
Humoral immune responses after primary and secondary immunization with monomeric flagellin from  were examined over 10 weeks in three groups of patients with putative autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis and lupoid hepatitis, in patients with allergy to an extrinsic antigen, and in azathioprine treated patients. Sera were titrated by tanned cell haemagglutination for total antibody and IgG antibody. In patients with autoimmune diseases and allergy the humoral immune response to flagellin was similar to that of matched controls with other illnesses, so that neither autoimmunity nor allergy could be attributed to any general overactivity' of the antibody producing system. In patients with autoimmune diseases treated with azathioprine there was no statistically significant depression of the primary or secondary humoral immune response to flagellin, as compared with appropriate controls. This could be explained by azathioprine having a predominantly anti-inflammatory action, influencing cellular more than humoral immune mechanisms, in being tolerogenic' in respect of autoantigens, or by a combination of these effects.
在10周的时间里,对三组疑似自身免疫性疾病(即系统性红斑狼疮、类风湿性关节炎和狼疮样肝炎)患者、对外源性抗原过敏的患者以及接受硫唑嘌呤治疗的患者,检测了用[具体来源未提及]的单体鞭毛蛋白进行初次和二次免疫后的体液免疫反应。通过鞣酸细胞血凝试验滴定血清中的总抗体和IgG抗体。在自身免疫性疾病患者和过敏患者中,对鞭毛蛋白的体液免疫反应与患有其他疾病的匹配对照相似,因此自身免疫和过敏都不能归因于抗体产生系统的任何一般性“过度活跃”。与适当的对照相比,接受硫唑嘌呤治疗的自身免疫性疾病患者对鞭毛蛋白的初次或二次体液免疫反应没有统计学上的显著抑制。这可以解释为硫唑嘌呤主要具有抗炎作用,对细胞免疫机制的影响大于体液免疫机制,对自身抗原具有“耐受性”,或者是这些作用的综合结果。